Globeflex Capital L P Palatin Technologies Inc Transaction History

Globeflex Capital L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$0.63 - $1.0 $59,690 - $94,747	-94,747 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$0.88 - $1.1 $108,416 - $135,520	-123,200 Reduced 56.53%	94,747 $95,000
Q2 2018 Aug 10, 2018	BUY	$0.91 - $1.45 $198,331 - $316,023	217,947 New	217,947 $211,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.76M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.